Table 3 Comparison of clinical data among the patients with COVID-19 with/without UC-MSCs treatment at discharge
Clinical data | UC-MSCs treatment group (n = 9) | Control group (n = 9) | P value |
|---|---|---|---|
Mechanical ventilation | 1/9 | 4/9 | 0.294 |
Oxygen support (duration days for each case) | |||
Low-flow oxygen support | 7/9 | 7/9 | 1.000 |
High-flow oxygen support | 3/9 | 5/9 | 0.637 |
Clinical symptoms (duration days for each case) | |||
Fever | 5/9 | 2/9 | 0.335 |
Fatigue | 4/9 | 5/9 | 1.000 |
Cough | 4/9 | 8/9 | 0.131 |
Shortness of breath | 1/9 | 5/9 | 0.131 |
Antibody at discharge (titer of antibody, s/co) | |||
IgM antibody | 24.62 (8.43, 45.97) | 76.89 (19.13, 187.20) | 0.114 |
IgG antibody | 19.93 (3.37, 33.59) | 21.50 (15.69, 121.10) | 0.174 |
Interval between admission and discharge (days) | 20.00 (17.50, 24.50) | 23.00 (20.00, 27.00) | 0.306 |
